ArticlePloS one2026

Direct-acting antiviral therapy is associated with a reduced risk of selected immune-mediated inflammatory diseases in chronic hepatitis C infection: A real-world cohort study.

Yeong-Jang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.